| Active Ingredient | EXEMESTANE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Adjuvant treatment of oestrogen-receptor-positive early breast cancer in postmenop ausal women following 2–3 years of tamoxifen therapy Advanced breast cancer in postmenop ausal women in whom antioe More ... |
| Caution | Abdominal pain; alopecia; anorexia; constipation; depression; dizziness; dyspepsia; fatigue; headache; hot flushes; insomnia; nausea; rash; sweating; vomiting. |
| Dose Range | 25mg once a day after a meal. |
| Drug Interactions | |
| Pregnancy | Avoid during pregnancy. |
| Breast Feeding | Breastfeeding is not recommended during exemestane therapy. |